2. Academic Validation
  3. 3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site

3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site

  • Bioorg Med Chem Lett. 2003 Jun 16;13(12):2055-8. doi: 10.1016/s0960-894x(03)00310-x.
Stephen W Wright 1,  Anthony A Carlo,  Dennis E Danley,  David L Hageman,  George A Karam,  Mahmoud N Mansour,  Lester D McClure,  Jayvardhan Pandit,  Gayle K Schulte,  Judith L Treadway,  Ing-Kae Wang,  Paul H Bauer
Affiliations

Affiliation

  • 1 Pfizer Central Research, Eastern Point Road, Box 8220-3141, Groton, CT 06340, USA. stephen_w_wright@groton.pfizer.com
PMID: 12781194 DOI: 10.1016/s0960-894x(03)00310-x
Abstract

3-(2-Carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid (MDL-29951), an antagonist of the glycine site of the NMDA Receptor, has been found to be an allosteric inhibitor of the Enzyme fructose 1,6-bisphosphatase. The compound binds at the AMP regulatory site by X-ray crystallography. This represents a new approach to inhibition of fructose 1,6-bisphosphatase and serves as a lead for further drug design.

Figures
Products